Search research articles
Contact Us
Filters
Showing results (661-670 of 679) with videos related to
Page
of 68
Sort By:
Journal of Neurology
|
July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients
G Balloy, J Pelletier, L Suchet, et al.
Breast Cancer Research and Treatment
|
November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry study
Hanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
Cancers
|
October 21, 2020
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Laura L Michel, Andreas D Hartkopf, Peter A Fasching, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2022
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry
Volkmar Müller, Alexander Hein, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2024
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry
Andreas D Hartkopf, Christina B Walter, Hans-Christian Kolberg, et al.
BMC Cancer
|
October 16, 2024
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
Philipp Ziegler, Andreas D Hartkopf, Markus Wallwiener, et al.
ESMO Open
|
November 24, 2022
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy
C Pixberg, M Zapatka, M Hlevnjak, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2025
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
Laura L Michel, Philipp Ziegler, Philipp Kreis, et al.
Geburtshilfe Und Frauenheilkunde
|
October 3, 2022
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT
Tobias Engler, Peter A Fasching, Diana Lüftner, et al.
Breast (Edinburgh, Scotland)
|
February 14, 2025
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer
Christina B Walter, Andreas D Hartkopf, Alexander Hein, et al.
Page
of 68
Search research articles
Search
Showing results (661-670 of 679) with videos related to
Sort By:
Page
of 68
Journal of Neurology
|
July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients
G Balloy, J Pelletier, L Suchet, et al.
Breast Cancer Research and Treatment
|
November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry study
Hanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
Cancers
|
October 21, 2020
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Laura L Michel, Andreas D Hartkopf, Peter A Fasching, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2022
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry
Volkmar Müller, Alexander Hein, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2024
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry
Andreas D Hartkopf, Christina B Walter, Hans-Christian Kolberg, et al.
BMC Cancer
|
October 16, 2024
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
Philipp Ziegler, Andreas D Hartkopf, Markus Wallwiener, et al.
ESMO Open
|
November 24, 2022
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy
C Pixberg, M Zapatka, M Hlevnjak, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2025
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
Laura L Michel, Philipp Ziegler, Philipp Kreis, et al.
Geburtshilfe Und Frauenheilkunde
|
October 3, 2022
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT
Tobias Engler, Peter A Fasching, Diana Lüftner, et al.
Breast (Edinburgh, Scotland)
|
February 14, 2025
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer
Christina B Walter, Andreas D Hartkopf, Alexander Hein, et al.
Page
of 68